Veeva Systems reported $3.46B of revenue over the trailing twelve months, +17% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $3.46B (to Q2 2027). Net income: $1.01B, trailing twelve months to Q2 2027. Operating margin: 30%, trailing twelve months to Q2 2027. EPS: $6.11, trailing twelve months to Q2 2027.

VEEVVeeva Systems

Healthcare

$296.04+6.1% 1Y

$296.04

$151.4352 weeks$306.22

VEEV as reported

Veeva Systems reported $3.46B of revenue over the trailing twelve months, +17% on the year before. 10 reported series are charted on this page, each one as filed.

$3.46B

Revenue, trailing twelve months · to Q2 2027 · +17% against the twelve months before

Net income: $1.01B
Net income · +25% year on year · trailing twelve months to Q2 2027
Operating margin: 30%
Operating margin · trailing twelve months to Q2 2027
EPS: $6.11
EPS · +26% year on year · trailing twelve months to Q2 2027

Details›

Every series Ryufin has for VEEV, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$3.46B	+17%	Q2 2027
Net income	$1.01B	+25%	Q2 2027
EPS	$6.11	+26%	Q2 2027
Gross margin	75%	n/a	Q2 2027
Operating margin	30%	n/a	Q2 2027
Net margin	29%	n/a	Q2 2027
ROE	13%	n/a	Q2 2027
ROA	11%	n/a	Q2 2027
Free cash flow	$481M	n/a	Q1 2021 · 25 quarters behind
P/E	48.5	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.